|
General Information
|
|
|
Product
|
CRMP2 Peptide
|
|
Description
|
Antigenic Blocking Peptide Collapsin response mediated protein 2 Antibody
|
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
|
Peptide Description
|
Synthetic peptide taken from within the region corresponding to AA 60-115 of the CRMP2 protein. The 26mer peptide was conserved in several other species. The selected peptide was post-synthetically modified to achieve highest antigenicity before coupling to carrier protein using hetero-bifunctional cross linker for Peptide Description preparation.
|
|
Accession #
|
NCBI: NP_001184222.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
|
Uniprot #
|
Q16555
|
|
Overview
|
Involved in neuronal development and polarity, axon growth and guidance, neuronal growth cone collapse, and cell migration. Is needed for signalling by class 3 semaphorins and later remodeling of the cytoskeleton.
|
|
Molecular Function
|
Dihydropyrimidinase activity; developmental protein
|
|
Subcellular Location
|
Cytoplasm; Cytoskeleton; Membrane
|
|
Expression
|
Ubiquitous
|
|
Structure
|
Homotetramer and heterotetramer with CRMP1, DPYSL3, DPYSL4 or DPYSL5. Intteracts via its C-terminus with the C-terminus of CYF1P1/SRA1. Also interacts with HTR4, CLN6 and MICALL1.
|
|
Alternative Nomenclature
|
CRAM antibody
DHPRP 2 antibody
Dihydropyrimidinase 2 antibody
DPYL 2 antibody
Musunc 33 antibody
N2A3 antibody
TOAD 64 antibody
ULIP 2 protein antibody
Unc-33-like phosphoprotein 2 antibody
|
CRMP2 Antibody
CRMP2 Antibody FITC
CRMP2 Antibody BIOTIN
CRMP2 Positive Control
